STAT3 and colorectal carcinoma: In this study, we extend our previous research to assess the inhibitory effects of regorafenib35 and two novel SHP-1 agonists, SC-4336 and SC-7837, on constitutive and inducible STAT3 phosphorylation in HCT-116 and HT-29 human CRC cells, respectively.